Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

Monthly Archives: February 2013

Home/2013/February
8 02, 2013

Celgene: FDA approval of POM “based on response rate.”

Tags: , , , , , |7 Comments

Here's Celgene's official press release about today's FDA approval of pomalidomide.  I will review what the news means to me--and my fellow patients and caregivers--this weekend. U.S. FOOD AND DRUG ADMINISTRATION APPROVES POMALYST® (POMALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA SUMMIT, NJ – (Feb. 8, 2013) – Celgene Corporation (NASDAQ:

8 02, 2013

BREAKING NEWS: FDA approves pomalidomide

Tags: , , , |0 Comments

Celgene spokesperson, Greg Geissman, emailed me four minutes ago with the good news: U.S. FOOD AND DRUG ADMINISTRATION APPROVES POMALYST® (POMALIDOMIDE) FOR THE TREATMENT OF PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA Official press release to follow. Feel good and keep smiling!  Pat

5 02, 2013

Financial Aid for Myeloma Patients and Caregivers

Tags: , , , |13 Comments

I'm so excited!  My 4th book, Financial Aid for Myeloma Patients and Caregivers, is available NOW!  The short, easy read lists 42 different funding sources to help pay for travel expenses, co-pays--even the cost of your medical insurance.  Several even send you free "stuff," ranging from complimentary hair care products and gift baskets to free

2 02, 2013

MYELOMA CINDERELLA: “NO ROLE FOR KEEPING BEST GUNS IN RESERVE”

Tags: , , , , , , |14 Comments

Our very own Myeloma Cinderella explores one of the four or five key controversial questions about myeloma therapy strategies this weekend: whether to use the newest and best drugs up-front, or keep them in reserve for relapse. The title of her column leaves no doubt about how suzierose feels: MYELOMA CINDERELLA: "NO ROLE FOR KEEPING

1 02, 2013

mSMART, OS update and inspirational friends

Tags: , , , , , |3 Comments

Let's start with a helpful link to Mayo Clinic's Medical Laboratory site: Multiple Myeloma Proper Diagnosis and Risk Stratification to Guide Treatment Here you will find an informative video and helpful charts that help explain how genetic testing works, and why Risk-Adapted Therapy (mSMART ) is an important tool for myeloma specialists. Next, listen to